These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20164113

  • 1. Metabolism of 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether (pyridalyl) in rats after repeated oral administration and a simple physiologically based pharmacokinetic modeling in brown and white adipose tissues.
    Nagahori H, Matsunaga H, Tomigahara Y, Isobe N, Kaneko H.
    Drug Metab Dispos; 2010 May; 38(5):824-32. PubMed ID: 20164113
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of pyridalyl in rats.
    Nagahori H, Saito K, Tomigahara Y, Isobe N, Kaneko H.
    Drug Metab Dispos; 2009 Dec; 37(12):2284-9. PubMed ID: 19773539
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of pyridalyl in rats: excretion, distribution, and biotransformation of dichloropropenyl-labeled pyridalyl.
    Nagahori H, Tomigahara Y, Isobe N, Kaneko H.
    J Agric Food Chem; 2009 Nov 25; 57(22):10845-51. PubMed ID: 19919122
    [Abstract] [Full Text] [Related]

  • 4. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 25; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 5. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb 25; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb 25; 46(2):114-27. PubMed ID: 8720299
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H, Sugimoto T, Ago M, Morino A, Takaichi M, Ogawa Y, Seki H, Matsuura C, Esumi Y.
    Arzneimittelforschung; 1999 Dec 25; 49(12):977-85. PubMed ID: 10635441
    [Abstract] [Full Text] [Related]

  • 8. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U, Breuer O, Swedmark S, Hoogstraate J.
    J Pharm Pharmacol; 2005 May 25; 57(5):587-97. PubMed ID: 15901348
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb 25; 46(2):106-13. PubMed ID: 8720298
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W, Ahr HJ, Hirayama M.
    Arzneimittelforschung; 1997 Aug 25; 47(8):939-48. PubMed ID: 9296280
    [Abstract] [Full Text] [Related]

  • 11. Decabromodiphenyl ether in the rat: absorption, distribution, metabolism, and excretion.
    Morck A, Hakk H, Orn U, Klasson Wehler E.
    Drug Metab Dispos; 2003 Jul 25; 31(7):900-7. PubMed ID: 12814967
    [Abstract] [Full Text] [Related]

  • 12. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
    Okezaki E, Terasaki T, Nakamura M, Nagata O, Kato H, Tsuji A.
    Drug Metab Dispos; 1988 Jul 25; 16(6):865-74. PubMed ID: 2907467
    [Abstract] [Full Text] [Related]

  • 13. MTBE inhaled alone and in combination with gasoline vapor: uptake, distribution, metabolism, and excretion in rats.
    Benson JM, Barr EB, Krone JR.
    Res Rep Health Eff Inst; 2001 May 25; (102):73-94; discussion 95-109. PubMed ID: 11504149
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of 14C-sulphadimethoxane in swine.
    Adams PE, Feil VJ, Paulson GD.
    Xenobiotica; 1996 Sep 25; 26(9):921-33. PubMed ID: 8893039
    [Abstract] [Full Text] [Related]

  • 15. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Jun 25; 25(6):732-9. PubMed ID: 9193875
    [Abstract] [Full Text] [Related]

  • 16. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
    Chan MP, Morisawa S, Nakayama A, Kawamoto Y, Sugimoto M, Yoneda M.
    Environ Toxicol; 2005 Oct 25; 20(5):533-41. PubMed ID: 16161119
    [Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 2000 Jul 25; 491():1-412. PubMed ID: 12563349
    [Abstract] [Full Text] [Related]

  • 18. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar 25; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar 25; 47(3):285-92. PubMed ID: 9105547
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar 25; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.